BRET-based ligand binding on BMG readers

  • Company/University: The University of Western Australia, Harry Perkins Institute of Medical Research and Dimerix Limited
  • Interviewee: Dr Kevin Pfleger (Director Biomedical Innovation)
  • Products used: PHERAstar and CLARIOstar
  • Method: ligand binding of GPCRs, protein-protein interaction, luminescence, BRET, NanoBRET, competitive binding
kevin-pfleger-thumbnail
Compatible readers
Newsletter Sign-up